Current role
Biotechnology · Healthcare
Board Member
2024-05-20–present
Roger Sawhney
Board Member
Actuate Therapeutics, Inc. (ACTU)Equibles does not estimate personal net worth.
Get an email with a short summary when Actuate Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ACTU alertsAbout Roger Sawhney
Roger Sawhney is recorded as Board Member at Actuate Therapeutics, Inc. (ACTU) since May 20, 2024. Actuate Therapeutics, Inc. reported in an 8-K filed August 14, 2024 that Roger Sawhney was appointed Director, effective May 20, 2024. Actuate Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Actuate Therapeutics, Inc. includes Daniel M. Schmitt (CEO and Board Member), Paul Lytle (CFO), Andrew P. Mazar (COO) and 7 others.
“each of Jason Keyes, Roger Sawhney, and Amy Ronneberg were appointed to the Company's Board of Directors (the "Board") on May 20, 2024.”
Affiliation history
-
Current
2024-05-20–present
Company network
Leadership on record at Actuate Therapeutics, Inc.
- Daniel M. Schmitt CEO, Board Member
- Paul Lytle CFO
- Andrew P. Mazar COO
- Aaron G.L. Fletcher Board Member
- Amy Ronneberg Board Member
- Dr. Dan Zabrowski Board Member
- Dr. Roger Sawhney Board Member
- Jason Keyes Board Member
- Martin H. Huber, MD Board Member
- Todd Thomson Board Member